Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Aptinyx Raises $70 Million in Series B Financing to Advance Growing Pipeline through Clinical Studies in Neurologic Disorders

by mparnell | Dec 18, 2017 | Portfolio News

Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer

by mparnell | Dec 7, 2017 | Portfolio News

Aptinyx Granted Fast Track Designation, Initiates Phase 1 for Second Clinical Candidate, NYX-783, in Post-Traumatic Stress Disorder

by mparnell | Dec 7, 2017 | Portfolio News

Collegium to License Rights to Commercialize Nucynta Franchise

by mparnell | Dec 4, 2017 | Portfolio News

Jazz Pharmaceuticals Announces Appointment Of Daniel Swisher As President And Chief Operating Officer

by mparnell | Dec 4, 2017 | Portfolio News

« Older Entries

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2023 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer